| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PGEN.1001356 |
| P953 | full work available at URL | http://dx.plos.org/10.1371/journal.pgen.1001356 |
| https://europepmc.org/articles/PMC3069107 | ||
| https://europepmc.org/articles/PMC3069107?pdf=render | ||
| https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1001356&type=printable | ||
| P932 | PMC publication ID | 3069107 |
| P698 | PubMed publication ID | 21483804 |
| P5875 | ResearchGate publication ID | 51042568 |
| P50 | author | Juan Carlos Roa | Q56380840 |
| Melissa Fazzari | Q61099538 | ||
| Anirban Maitra | Q63019787 | ||
| Reid F Thompson | Q41312233 | ||
| John Greally | Q42667137 | ||
| P2093 | author name string | Li Zhou | |
| Amit Verma | |||
| Ari Melnick | |||
| Yiting Yu | |||
| Marcia Canto | |||
| Masako Suzuki | |||
| Christina Montagna | |||
| Jean Wang | |||
| Joanna Opalinska | |||
| Davendra Sohal | |||
| Hector Alvarez | |||
| Tushar Bhagat | |||
| Elizabeth A. Montgomery | |||
| Linda Cannizzaro | |||
| Yongkai Mo | |||
| J. Mollenhauer | |||
| Kerry B. Dunbar | |||
| K. H. Ramesh | |||
| Stephen J. Meltzer | |||
| P2860 | cites work | LUMA (LUminometric Methylation Assay)--a high throughput method to the analysis of genomic DNA methylation | Q53626812 |
| Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia | Q56418625 | ||
| Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers | Q67920829 | ||
| Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays | Q77580360 | ||
| Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH | Q79850195 | ||
| Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis | Q80998934 | ||
| Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions | Q82844125 | ||
| Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line | Q39940721 | ||
| Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells. | Q40425709 | ||
| CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. | Q40455557 | ||
| Alterations in DNA methylation: a fundamental aspect of neoplasia | Q41617101 | ||
| A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus | Q41897097 | ||
| Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? | Q47562024 | ||
| Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. | Q52038511 | ||
| Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. | Q53342403 | ||
| Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma | Q53367270 | ||
| APC gene mutations in the mutation cluster region are rare in esophageal cancers. | Q53468433 | ||
| Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts | Q24629646 | ||
| Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers | Q24649562 | ||
| Inflammation and cancer | Q24649640 | ||
| Comparative isoschizomer profiling of cytosine methylation: the HELP assay | Q24685607 | ||
| Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk | Q28244692 | ||
| Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 | ||
| Chemokine signaling via the CXCR2 receptor reinforces senescence | Q28283948 | ||
| Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 | ||
| Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression | Q33291071 | ||
| An integrative genomic and epigenomic approach for the study of transcriptional regulation | Q33325492 | ||
| Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features | Q33326627 | ||
| A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry | Q33567042 | ||
| CpG island methylator phenotypes in aging and cancer. | Q33765672 | ||
| Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation | Q34238141 | ||
| Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study | Q34238147 | ||
| DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. | Q34433577 | ||
| Clinical practice. Barrett's Esophagus | Q34563466 | ||
| Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma | Q34621907 | ||
| Role of CXCL1 in tumorigenesis of melanoma. | Q34724089 | ||
| DNA methylation in cancer: too much, but also too little | Q34770545 | ||
| Epigenomics: beyond CpG islands. | Q35778671 | ||
| CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer | Q36228506 | ||
| Esophageal adenocarcinoma arising in Barrett esophagus | Q37169303 | ||
| The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target | Q37182283 | ||
| High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. | Q37259044 | ||
| MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation | Q37396081 | ||
| Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus | Q37495646 | ||
| Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction | Q37527489 | ||
| Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications | Q38440539 | ||
| Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. | Q38519052 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA methylation | Q874745 |
| carcinogenesis | Q1637543 | ||
| P304 | page(s) | e1001356 | |
| P577 | publication date | 2011-03-31 | |
| P1433 | published in | PLOS Genetics | Q1893441 |
| P1476 | title | Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis | |
| Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis | |||
| P478 | volume | 7 |
| Q35878807 | A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets |
| Q39374385 | A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation |
| Q40512450 | A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets |
| Q35107545 | Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q |
| Q33728558 | An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer. |
| Q34318280 | Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia |
| Q36257990 | Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host |
| Q38151814 | Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma |
| Q53236379 | Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma |
| Q64086787 | Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients |
| Q39338522 | Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development |
| Q91708347 | DNA Methylation Cancer Biomarkers: Translation to the Clinic |
| Q37207287 | DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus |
| Q36018367 | Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer |
| Q57433696 | Environmentally Induced Alterations in the Epigenome Affecting Obesity and Cancer in Minority Populations |
| Q37992481 | Epigenetic biomarkers in esophageal cancer |
| Q98290375 | Epigenetic mechanisms and the hallmarks of cancer: an intimate affair |
| Q28743678 | Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors |
| Q50904123 | Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation |
| Q38210930 | Epigenetics in esophageal cancers. |
| Q36205151 | Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis |
| Q35666522 | Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q42175459 | Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer |
| Q39124834 | Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. |
| Q37354559 | Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma |
| Q38940530 | Genomics of Esophageal Cancer and Biomarkers for Early Detection |
| Q35696490 | Heritable Transmission of Diabetic Metabolic Memory in Zebrafish Correlates With DNA Hypomethylation and Aberrant Gene Expression |
| Q36724881 | High Resolution Methylome Analysis Reveals Widespread Functional Hypomethylation during Adult Human Erythropoiesis |
| Q38484630 | High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells |
| Q37085575 | Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma |
| Q89595613 | Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data |
| Q36725997 | Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma |
| Q37974887 | Inflammation, DNA methylation and colitis-associated cancer |
| Q35582141 | Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival |
| Q83226924 | Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts |
| Q36214558 | Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas |
| Q64936905 | Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers. |
| Q35871204 | Methylation of Werner syndrome protein is associated with the occurrence and development of invasive meningioma via the regulation of Myc and p53 expression |
| Q33880512 | Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms |
| Q37943774 | Molecular Mechanisms of Barrett’s Esophagus |
| Q90665246 | Molecular epigenomic subtypes of Barrett neoplasia |
| Q64098709 | Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer |
| Q36089332 | Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis |
| Q34547790 | Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus |
| Q39138075 | Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer |
| Q35651346 | Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes |
| Q37487009 | Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis |
| Q34036817 | Relationship between methylation and colonic inflammation in inflammatory bowel disease |
| Q38881033 | Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine |
| Q27026253 | Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction |
| Q37452434 | Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma |
| Q36358569 | Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma |
| Q36187424 | Targeting chemokine pathways in esophageal adenocarcinoma |
| Q38002967 | Targeting epigenetic mediators of gene expression in thoracic malignancies |
| Q38132057 | The '-omics' revolution and oesophageal adenocarcinoma |
| Q90474658 | The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma |
| Q35815874 | The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma |
| Q42698395 | The early pregnancy placenta foreshadows dna methylation alterations of solid tumors |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q90447370 | The significance of chemokine CXCL-8 in esophageal carcinoma |
| Q38212001 | The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression |
| Q54318784 | Translational research on Barrett's esophagus. |
Search more.